---
category: news
title: "Evaluating eligibility criteria of oncology trials using real-world data and AI"
excerpt: "Time zero was set to be the start of the corresponding line of therapy. Finally, we performed survival analysis for the emulated trials using the hazard ratio of the overall survival as the outcome. Each individual was followed until the occurrence of ..."
publishedDateTime: 2021-04-07T16:33:00Z
originalUrl: "https://www.nature.com/articles/s41586-021-03430-5"
webUrl: "https://www.nature.com/articles/s41586-021-03430-5"
type: article
quality: 33
heat: 33
published: false

provider:
  name: Nature
  domain: nature.com

topics:
  - AI

images:
  - url: "https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41586-021-03430-5/MediaObjects/41586_2021_3430_Fig2_HTML.png"
    width: 685
    height: 799
    isCached: true

secured: "RdT1Nt62JQN3aKY7Jvkj8kOX1TsSj8IqqS5QLF5giD5YUuitYDCwhGUf+PDE/+JeRvYsUoaG156+2P026fnYyJvkR/YvtWkHYO+6evE6RCdtfmywCfUxEyPFqyIZpe1BM5faCcvjT2X8KRtWAwcd81OCqp9OWstcUezYuBYLQNLuQuWKZZk1D7WHtGKhWyzOQtMJyW3ciPLo1g9g+10z/xizeduaOcQ4EQrd4O5G2I4VchpbHWpXTlncXEiK7J12XCI9QnbsUiCN3/WA9+veDzhHeLJ8FWpWUH+kt4Sp0uL/b+99z+kif5Ubc9jOQFieqn376duHZteZ7M7t4JutaUXRBa6i3fAOkZGeLIKbJ68=;+mSvHZRcrfO5tFR7QIbeBw=="
---

